Emergent BioSolutions Inc. Logo

Emergent BioSolutions Inc. (0IGA)

LSE

Currency in USD
6.79
-0.02 (-0.37%)

Closed

Sep 28, 2026

Day's Range

6.64
6.81

52 wk Range

4.37
13.91

Overview - 0IGA - Emergent BioSolutions Inc.

Key Statistics

Valuation

Enterprise Value

802.28M

P/E (Trailing)

‪0.02‬

Price / Sales (TTM)

‪1.75‬

Price / Book

‪1.03‬

EV / EBITDA

‪3.45‬

Profitability

Gross Margin

‪95.60%‬

Profit Margin

‪-22.95%‬

Operating Margin

‪28.34%‬

Return on Assets

‪6.93%‬

Return on Equity

‪-40.29%‬

Ownership

Shares Outstanding

50.94M

Float

49.06M

Held by Insiders

‪4.25%‬

Held by Institutions

‪90.73%‬

Price stats

Beta

‪2.33‬

50-Day Avg

‪2.24‬

200-Day Avg

‪4.13‬

News Teaser - 0IGA - Emergent BioSolutions Inc.

News & Analysis

View all news

Market Cap - 0IGA - Emergent BioSolutions Inc.

Peers - 0IGA - Emergent BioSolutions Inc.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.

Profile Summary - 0IGA - Emergent BioSolutions Inc.

About

Emergent BioSolutions Inc. is a life sciences company focused on preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats. Its current business centers on medical countermeasures and specialty products, including public health protection tools used by government…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees900
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.